Osteopore Limited (ASX:OSX) Secures EU MDR Approval for Custom Implants
Osteopore (ASX:OSX) secures EU MDR approval for custom orthopaedic and cranial implants, expanding its market in Europe.
Osteopore (ASX:OSX) secures EU MDR approval for custom orthopaedic and cranial implants, expanding its market in Europe.
Dateline Resources (ASX:DTR) secures mining and rare earth exploration rights for its Colosseum Project, enhancing its growth prospects.
Cochlear Limited (ASX:COH) confirms it can continue duty-free imports of hearing implants despite new US tariffs.
Trigg Minerals (ASX:TMG) secures antimony exemption from US tariffs, propelling the development of its Wild Cattle Creek project.
Abacus Group (ASX:ABG) receives unsolicited proposal from Ki Corporation and Public Storage to acquire additional ASK securities.
Dropsuite Limited (ASX:DSE) has been declared to have unacceptable circumstances by the Takeovers Panel due to major shareholder Topline’s non-compliance.
Structural Monitoring Systems PLC (ASX:SMN) announces an update on US reciprocal tariffs, confirming tariff-free status for its compliant avionics products and ongoing monitoring of trade impacts.
Mesoblast (ASX:MSB) announces its allogeneic cell therapies are exempt from U.S. tariffs as ‘U.S. Country of Origin’ products.
Orthocell (ASX:OCC) secures FDA clearance for Remplir™, enabling entry into the US $1.6 billion nerve repair market.
Echo IQ (ASX:EIQ) partners with Mayo Clinic Platform to advance EchoSolv HF and progress towards FDA clearance for its heart failure solution.